*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Acipimox</strong> (CAS: 2507-84-0; Formula: C<sub>6</sub>H<sub>7</sub>NO<sub>2</sub>) is a niacin derivative synthesized via condensation of nicotinic acid with acetone. It functions as an antilipemic agent primarily used to lower plasma triglycerides and free fatty acids.</p>
<h3>Application</h3>
<ul>
<li>Dyslipidemia management in cardiovascular risk reduction protocols.</li>
<li>Adjunct therapy for hypertriglyceridemia when statins are insufficient.</li>
<li>Lipid-lowering formulations for metabolic syndrome patients.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in severe hepatic impairment or active peptic ulcers. Store below 25°C in dry, light-resistant conditions. Monitor liver enzymes periodically during long-term industrial formulation use.</p>